Global obesity drug expansion: Lilly and Novo eye growth
The focus is on global obesity drug expansion as Lilly and Novo Nordisk broaden production capacity to meet anticipated growth and wider medical coverage
Pfizer Novo Nordisk Competition Heats Up as Pfizer Sues
The Pfizer Novo Nordisk competition is intensifying as Pfizer's lawsuit alleges Novo Nordisk's efforts to suppress market rivals and potentially hinder obesity